| Host conditioning and rejection monitoring in hepatocyte transplantation in humans KA Soltys, K Setoyama, EN Tafaleng, AS Gutiérrez, J Fong, K Fukumitsu, ... Journal of hepatology 66 (5), 987-1000, 2017 | 122 | 2017 |
| Induced pluripotent stem cells model personalized variations in liver disease resulting from α1‐antitrypsin deficiency EN Tafaleng, S Chakraborty, B Han, P Hale, W Wu, A Soto‐Gutierrez, ... Hepatology 62 (1), 147-157, 2015 | 90 | 2015 |
| Amelioration of hyperbilirubinemia in gunn rats after transplantation of human induced pluripotent stem cell-derived hepatocytes Y Chen, Y Li, X Wang, W Zhang, V Sauer, CJ Chang, B Han, ... Stem cell reports 5 (1), 22-30, 2015 | 76 | 2015 |
| Increased reprogramming of human fetal hepatocytes compared with adult hepatocytes in feeder-free conditions MC Hansel, R Gramignoli, W Blake, J Davila, K Skvorak, K Dorko, ... Cell transplantation 23 (1), 27-38, 2014 | 24 | 2014 |
| Cellular Location of HNF4α is Linked With Terminal Liver Failure in Humans RM Florentino, NA Fraunhoffer, K Morita, K Takeishi, A Ostrowska, ... Hepatology Communications, 2020 | 20 | 2020 |
| Modeling and therapy of human liver diseases using induced pluripotent stem cells: how far have we come? A Soto‐Gutierrez, E Tafaleng, V Kelly, J Roy‐Chowdhury, IJ Fox Hepatology 53 (2), 708-711, 2011 | 15 | 2011 |
| Hepatocyte nuclear factor 4 alpha 2 messenger RNA reprograms liver‐enriched transcription factors and functional proteins in end‐stage cirrhotic human hepatocytes EN Tafaleng, A Mukherjee, A Bell, K Morita, J Guzman‐Lepe, N Haep, ... Hepatology Communications 5 (11), 1911-1926, 2021 | 11 | 2021 |
| Embryonic and induced pluripotent stem cells as a model for liver disease H Yagi, E Tafaleng, M Nagaya, MC Hansel, SC Strom, IJ Fox, ... Critical Reviews™ in Biomedical Engineering 37 (4-5), 2009 | 11 | 2009 |
| Synthetic human livers for modeling metabolic diseases EN Tafaleng, MR Malizio, IJ Fox, A Soto-Gutierrez Current opinion in gastroenterology 37 (3), 224-230, 2021 | 3 | 2021 |
| The rate of disappearance of intracellular α-l-antitrypsin correlates with liver disease severity in iPScderived hepatocytes generated from PIZZ α-1-antitrypsin deficiency … E Tafaleng, B Han, P Hale, S Chakraborty, A Soto-Gutierrez, ... Hepatology 58, 2013 | 3 | 2013 |
| Polymorphisms Associated with Metabolic Dysfunction-Associated Steatotic Liver Disease Influence the Progression of End-Stage Liver Disease ZN Kocas-Kilicarslan, Z Cetin, LAP Faccioli, T Motomura, S Amirneni, ... Gastro Hep Advances 3 (1), 67-77, 2023 | 2 | 2023 |
| Evaluation of Human Hepatocyte Drug Metabolism Carrying High-Risk or Protection-Associated Liver Disease Genetic Variants LAP Faccioli, Z Cetin, ZN Kocas-Kilicarslan, K Ortiz, Y Sun, Z Hu, ... International Journal of Molecular Sciences 24 (17), 13406, 2023 | 2 | 2023 |
| Variants in autophagy genes MTMR12 and FAM134A are putative modifiers of the hepatic phenotype in α1-antitrypsin deficiency EN Tafaleng, J Li, Y Wang, T Hidvegi, A Soto-Gutierrez, AE Locke, ... Hepatology, 10.1097, 2024 | 1 | 2024 |
| Human hepatocellular response in cholestatic liver diseases K Ortiz, Z Cetin, Y Sun, Z Hu, T Kurihara, EN Tafaleng, RM Florentino, ... Organogenesis 19 (1), 2247576, 2023 | 1 | 2023 |
| A non-human primate model of acute liver failure suitable for testing liver support systems RS Kalsi, A Ostrowska, A Olson, M Quader, M Deutsch, NJ Arbujas-Silva, ... Frontiers in Medicine 9, 964448, 2022 | 1 | 2022 |
| FXR-mediated Signaling is Impaired in iPS-derived Hepatocytes in PFICI (Byler) Disease and is Enhanced by 4-Phenylbutyrate: 17 B Han, EN Tafaleng, F Chen, A Dreyzin, BL Shneider, IJ Fox Hepatology 58, 215A-216A, 2013 | 1 | 2013 |
| GENERATION OF INDUCED PLURIPOTENT STEM CELLS FROM THE HEPATOCYTES OF NORMAL PATIENTS AND PATIENTS WITH METABOLIC LIVER DISEASES: 182 MC Hansel, E Tafaleng, M Nagaya, A Soto-Gutierrez, R Gramignoli, ... Hepatology 52, 413A-414A, 2010 | 1 | 2010 |
| Transcriptional Therapy Based- Lipid Nanoparticles and mRNA for the Treatment of End-Stage Liver Disease Soto-Gutierrez A, B AW, O AK, T EN, F IJ, F LAP, H N, Diaz-Aragon R, ... WO Patent App. 2,023,133,489, 2023 | | 2023 |
| From a Single Cell to a Whole Human Liver: Disease Modeling and Transplantation T Motomura, LAP Faccioli, R Diaz-Aragon, ZN Kocas-Kilicarslan, N Haep, ... Seminars in Liver Disease 42 (04), 413-422, 2022 | | 2022 |
| Compositions and methods for treating liver disease Soto-Gutierrez A, B A, F Navarro N, Guzman-Lepe J, H S, M GK, O A, F IJ, ... WO Patent App. 2,021,076,566, 2021 | | 2021 |
